Although the small numbers do not allow definitive conclusions, BMP levels in these individuals had a similar pattern to those seen in LRRK2 G2019S+ subjects, i.e., BMP levels were elevated in the compound mutation carriers, but did not differ between those with and without PD (Supplemental Table 4). This evidence concerns the gene LRRK2 and Parkinson disease.